Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Equipment

Integrity Applications Inc

+ Add to Watchlist

IGAP:US

5.0000 USD 0.00000.00%

As of 20:10:08 ET on 02/27/2015.

Snapshot for Integrity Applications Inc (IGAP)

Open: - Day's Range: - Volume: 550
Previous Close: 5.0000 52wk Range: 4.9000 - 8.5000 1-Yr Rtn: -41.18%

Stock Chart for IGAP

No chart data available.
  • IGAP:US 5.0000
  • 1D
  • 1M
  • 1Y
5.0000
Interactive IGAP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IGAP

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.7254
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 26.53
Shares Outstanding (M) 5.31
30 Day Average Volume 476
Price/Book (mrq) -
Price/Sale (ttm) 982.2222
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IGAP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IGAP

Integrity Applications, Inc. designs, develops, and commercializes medical devices. The Company manufactures non-invasive blood glucose monitoring devices. Integrity Applications offers its products to the medical industry, primarily to people with diabetes, in the United States and Israel.

Avner GalChairman/CEO/Pres/Co-FounderEran HertzChief Financial Officer
David MalkaExec VP:Operations/FounderD Rafael ToledanoDirector:Investor Relations
More Company Profile & Key Executives for IGAP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil